Ampio Pharmaceuticals, Inc. Made Headway
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) jumped higher at $0.03, a gain of 28.3%. On Wed, Nov 09, 2022, AMPE:NYSEMKT touched a New 2-Week Intraday Low of $0.02. The stock appeared on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:22 PM in the 'SPLIT' category. From Wed, Oct 26, 2022, the stock recorded 0.00% Up Days and 9.09% Green Days
The stock spiked on Wed, Oct 19, 2022 at $0.04 with a volume of 2M+.
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- Merrimack Pharmaceuticals, Inc. (MACK:NASDAQ), 212.75%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Outset Medical Inc. (OM:NASDAQ), 29.9%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 29.6%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Riskified Ltd. Class A (RSKD:NYSE), 24.94%
- Health Catalyst, Inc. (HCAT:NASDAQ), 23.34%
- Quotient Technology Inc. (QUOT:NYSE), 22.81%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 22.8%
- Vivint Smart Home, Inc. (VVNT:NYSE), 20.57%